ArticleSignal transduction and targeted therapy

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.

Nicholas L Syn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.